Adalimumab Therapy Reduces Treatment Burden in Multifocal Choroiditis/Punctate Inner Choroidopathy.

Ho B, Baghdasaryan E, Goldberg NR

Open source

DOI
10.1080/09273948.2026.2708703
Published
2026 Sep
Container
Ocular immunology and inflammation
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/09273948.2026.2708703,
  title = {Adalimumab Therapy Reduces Treatment Burden in Multifocal Choroiditis/Punctate Inner Choroidopathy.},
  author = {Ho B and Baghdasaryan E and Goldberg NR},
  year = {2026},
  journal = {Ocular immunology and inflammation},
  doi = {10.1080/09273948.2026.2708703},
  url = {https://doi.org/10.1080/09273948.2026.2708703}
}

RIS

TY  - JOUR
TI  - Adalimumab Therapy Reduces Treatment Burden in Multifocal Choroiditis/Punctate Inner Choroidopathy.
AU  - Ho B
AU  - Baghdasaryan E
AU  - Goldberg NR
PY  - 2026
JO  - Ocular immunology and inflammation
DO  - 10.1080/09273948.2026.2708703
UR  - https://doi.org/10.1080/09273948.2026.2708703
ER  - 

APA

B, H., E, B., & NR, G. (2026). Adalimumab Therapy Reduces Treatment Burden in Multifocal Choroiditis/Punctate Inner Choroidopathy.. Ocular immunology and inflammation. https://doi.org/10.1080/09273948.2026.2708703

Source records